Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 45865-551 by Medsource Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pdp - 551
This is a description of Topiramate tablets in 25mg strength. It is a generic version of the drug Topamax. The text contains dosage instructions advising taking the tablet(s) twice daily. The medication should be taken carefully as it may cause dizziness and drowsiness, especially if alcohol is consumed.*
chemical-structure - chemical structure
figure-1jpg - figure 1
The text describes a figure denoted as Figure 1 which represents the Kaplan-Meier estimates of cumulative rates for time to the first seizure. The graph displays the days on the X-axis and the different dosages of Topiramate (in mg/day) on the Y-axis. The cumulative rates of seizures are also represented on the Y-axis. The different dosages are represented by a different color line. The figure has a title but no further information is provided.*
figure-2 - figure 2
This text is providing data related to the change in the average monthly rate of migraine periods during a double-blind phase with different doses of topiramate compared to a placebo group. The data is presented in a chart with different groups based on the dosage of topiramate, and the sample sizes for each group are provided. The study is labeled as Study 10 and Study 11. The text also includes two asterisks indicating significant differences (p < 0.001) between the groups.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.